UCB Pharma (Japan)
Alternate names Union chimique belge, ユーシービージャパン株式会社
Parent institution UCB Pharma (Belgium)
ROR: Yes
Works count: 52
Citations count: 710
The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression
2015 · Tatsuya Atsumi, Kazuhiko Yamamoto, et al. · Annals of the Rheumatic Diseases
Separation of Antiepileptogenic and Antiseizure Effects of Levetiracetam in the Spontaneously Epileptic Rat (SER)
2005 · Hai Yan, Jiqun Cai, et al. · Epilepsia
Potentials and limitations of nonclinical safety assessment for predicting clinical adverse drug reactions: correlation analysis of 142 approved drugs in Japan
2013 · Chihiro Tamaki, Takashi Nagayama, et al. · The Journal of Toxicological Sciences